InvestorsObserver
×
News Home

Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go?

Tuesday, April 19, 2022 09:45 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go?

InvestorsObserver is giving Kala Pharmaceuticals Inc (KALA) an Analyst Rating Rank of 27, meaning KALA is ranked higher by analysts than 27% of stocks. The average price target for KALA is $4.458 and analyst’s rate the stock as a Buy.

Overall Score - 3.9
Wall Street analysts are rating KALA a Buy today. Find out what this means to you and get the rest of the rankings on KALA!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Kala Pharmaceuticals Inc Stock Today?

Kala Pharmaceuticals Inc (KALA) stock is trading at $0.85 as of 9:39 AM on Tuesday, Apr 19, an increase of $0.06, or 7.75% from the previous closing price of $0.79. The stock has traded between $0.80 and $0.86 so far today. Volume today is light. So far 557 shares have traded compared to average volume of 3,476,140 shares. Click Here to get the full Stock Report for Kala Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App